表紙
市場調查報告書

歐洲的CGM (持續血糖監測系統) 市場分析、預測:用戶數,醫療費償付政策,CGM零組件 (葡萄糖感測器、變送器),糖尿病人口 (第1型、2型)

Europe CGM Market, Users, Reimbursement Policy, Continuous Glucose Monitoring Components (Glucose Sensor, Transmitter), Diabetes (Type1 & 2) Population and Forecast

出版商 Renub Research 商品編碼 661555
出版日期 內容資訊 英文 116 Pages
商品交期: 最快1-2個工作天內
價格
歐洲的CGM (持續血糖監測系統) 市場分析、預測:用戶數,醫療費償付政策,CGM零組件 (葡萄糖感測器、變送器),糖尿病人口 (第1型、2型) Europe CGM Market, Users, Reimbursement Policy, Continuous Glucose Monitoring Components (Glucose Sensor, Transmitter), Diabetes (Type1 & 2) Population and Forecast
出版日期: 2018年07月02日內容資訊: 英文 116 Pages
簡介

歐洲的CGM (持續血糖監測系統) 市場,預計至2024年末達到24億美元。

本報告提供歐洲的CGM (持續血糖監測系統) 市場相關調查分析,各國市場分析,成長促進因素,課題等相關的系統性資訊。

第1章 摘要整理

第2章 歐洲的CGM (持續血糖監測系統) 用戶

第3章 歐洲的CGM (持續血糖監測系統) 市場市場、預測

第4章 CGM (持續血糖監測系統) 市場:各零件

  • 葡萄糖感測器市場、預測
  • CGM變速箱市場、預測

第5章 市場佔有率:各國

第6章 醫療費償付模式:歐洲的CGM (持續血糖監測系統)

第7章 Abbott的 「FreeStyle Libre」 vs CGM (持續血糖監測系統)

第8章 英國的糖尿病人口

  • 整體糖尿病人口
    • 第一型糖尿病人口
    • 第二型糖尿病人口

第9章 英國:CGM市場、預測

  • 英國的CGM市場:各零件
    • 葡萄糖感測器市場、預測
    • CGM變送器市場、預測

第10章 英國:CGM用戶數

第11章 英國的CGM醫療費償付

第12章 德國的糖尿病人口

第13章 德國:CGM市場、預測

第14章 德國:CGM用戶數

第15章 德國的CGM醫療費償付

第16章 荷蘭的糖尿病人口

第17章 荷蘭:CGM市場、預測

第18章 荷蘭:CGM用戶數

第19章 荷蘭的CGM醫療費償付

第20章 瑞典的糖尿病人口

第21章 瑞典:CGM市場、預測

第22章 瑞典:CGM用戶數

第23章 瑞典的CGM醫療費償付

第24章 法國的糖尿病人口

第25章 法國:CGM市場、預測

第26章 法國:CGM用戶數

第27章 法國的CGM醫療費償付

第28章 瑞士的糖尿病人口

第29章 瑞士:CGM市場、預測

第30章 瑞士:CGM用戶數

第31章 瑞士的CGM醫療費償付

第32章 促進成長要素

  • 幾個國家持續的正成本效益分析
  • 對患者、醫生的雙方來說方便的CGM技術

第33章 課題

  • 臨床上的有效性相關爭議
目錄

Europe CGM Market is expected to surpass US$ 800 Million by the end of year 2024. Good healthcare infrastructure, rising healthcare expenditure and awareness of patients regarding CGM technology in Europe will further accelerate the market of Continuous Glucose Monitoring (CGM) device. Continuous Glucose Monitoring (CGM) device are comparatively new innovation in diabetes management. The conventional technique that permit users for one time check of glucose levels, but the CGM systems manage, monitor and inform the user if the glucose level nears current levels. The CGM system measures glucose from the tissues as compared to manual testing of blood by a finger-stick glucose meter assists in identifying glucose levels for a longer span of time.

Generally people who suffer from diabetes develop poor habits over the years which gradually seem hard to break. Using CGM systems that assist to control the desired glucose level by well awareness and understanding of food intake and blood glucose trends after eating specific foods.

Germany & France CGM Market will remain a dominant force in European Region

According to this market research report Germany & France is expected to be a dominant force in Europe Continuous Glucose Monitoring (CGM) market. The adoption of CGM device is comparatively faster in Sweden compared to other European region. As per many diabetes experts, CGM is the compatible device for effective diabetes management for people having severe complications (hypoglycemia or hyperglycemia) in day to day life.

European Countries Reimbursement Policies on CGM Device

This report provides complete assessment of CGM reimbursement for specific countries that includes: United Kingdom, Germany, France, Sweden, Switzerland and Netherlands. Many countries provide CGM reimbursement to pediatric, gestational diabetes and type 1 diabetes patients only. It is anticipated that continuous glucose monitoring systems will be widely accessible to all diabetes patients whether it type 1 or type 2.

Renub Research latest study “Europe CGM Market, Users, Reimbursement Policy, Continuous Glucose Monitoring Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast” provides a detailed and comprehensive insight of the Europe CGM Market. This report studies the Continuous Glucose Monitoring (CGM) market from 3 view points:

  • CGM Market
  • CGM Users
  • CGM Reimbursements Policy

Client can purchase this report in sections through Purchase by Chapter Tab given above.

Countries Covered

  • 1. Germany
  • 2. France
  • 3. Netherlands
  • 4. Switzerland
  • 5. Sweden
  • 6. United Kingdom

Scope of the Report

  • CGM Market & Forecast: We have defined CGM market of 6 countries. Market data from 2010 to 2017 and Forecast from 2018 to 2024.
  • CGM Users & Forecast: We have defined CGM number of Users of 6 countries. Market data from 2010 to 2017 and Forecast from 2018 to 2024.
  • Reimbursement Policy: Report provides Reimbursement Policy on CGM for 6 countries individually along with global CGM (Continuous Glucose Monitoring) reimbursement model.
  • Diabetes Population: Report covers 6 Countries Type 1 and Type 2 Diabetes Population Numbers and Forecast.
  • Growth Factors for CGM: This topic studies the factor which is helping the CGM industry to grow.
  • Challenges for CGM: This industry shows the problems being faced by the CGM technology.

Table of Contents

1. Executive Summary

2. Europe-CGM User (2010-2024)

3. Europe-CGM Market & Forecast (2010-2024)

4. By Components-CGM Market (2010-2024)

  • 4.1. Glucose Sensor Market & Forecast
  • 4.2. CGM Transmitter Market & Forecast

5. Market Share-By Countries

6. Reimbursement Model-Europe CGM (Continuous Glucose Monitoring)

7. Abbott Freestyle Libre vs CGM (Continuous Glucose Monitoring)

8. United Kingdom-Diabetes Population (2010-2024)

  • 8.1. Total Diabetes Population
    • 8.1.1. Type 1 Diabetes Population
    • 8.1.2. Type 2 Diabetes Population

9. United Kingdom - CGM Market & Forecast

  • 9.1. United Kingdom - CGM Market by Components
    • 9.1.1. Glucose Sensor Market & Forecast
    • 9.1.2. CGM Transmitter Market & Forecast

10. United Kingdom-CGM User (2010-2024)

11. CGM Reimbursement in United Kingdom

12. Germany-Diabetes Population (2010-2024)

  • 12.1. Total Diabetes Population
    • 12.1.1. Type 1 Diabetes Population
    • 12.1.2. Type 2 Diabetes Population

13. Germany - CGM Market & Forecast

  • 13.1. Germany - CGM Market by Components
    • 13.1.1. Glucose Sensor Market & Forecast
    • 13.1.2. CGM Transmitter Market & Forecast

14. Germany-CGM User (2010-2024)

15. CGM Reimbursement in Germany

16. Netherlands-Diabetes Population (2010-2024)

  • 16.1. Total Diabetes Population
    • 16.1.1. Type 1 Diabetes Population
    • 16.1.2. Type 2 Diabetes Population

17. Netherlands - CGM Market & Forecast

  • 17.1. Netherlands - CGM Market by Components
    • 17.1.1. Glucose Sensor Market & Forecast
    • 17.1.2. CGM Transmitter Market & Forecast

18. Netherlands-CGM User (2010-2024)

19. CGM Reimbursement in Netherlands

20. Sweden-Diabetes Population (2010-2024)

  • 20.1. Total Diabetes Population & Forecast
    • 20.1.1. Type 1 Diabetes Population
    • 20.1.2. Type 2 Diabetes Population

21. Sweden - CGM Market & Forecast

  • 21.1. Sweden-CGM Market by Components
    • 21.1.1. Glucose Sensor Market & Forecast
    • 21.1.2. CGM Transmitter Market & Forecast

22. Sweden-CGM User (2010-2024)

23. CGM Reimbursement in Sweden

24. France-Diabetes Population (2010-2024)

  • 24.1 Diabetes Population
    • 24.1.1. Type 1 Diabetes Population
    • 24.1.2. Type 2 Diabetes Population

25. France - CGM Market & Forecast

  • 25.1. France - CGM Market by Components
    • 25.1.1. Glucose Sensor Market & Forecast
    • 25.1.2. CGM Transmitter Market & Forecast

26. France-CGM User (2010-2024)

27. CGM Reimbursement in France

28. Switzerland-Diabetes Population (2010-2024)

  • 28.1. Total Diabetes Population
    • 28.1.1. Type 1 Diabetes Population
    • 28.1.2. Type 2 Diabetes Population

29. Switzerland - CGM Market & Forecast

  • 29.1. Switzerland - CGM Market by Components
    • 29.1.1. Glucose Sensor Market & Forecast
    • 29.1.2. CGM Transmitter Market & Forecast

30. Switzerland-CGM User (2010-2024)

31. CGM Reimbursement in Switzerland

32. Growth Drivers

  • 32.1. Continuous Positive Cost Effective Analysis by Several Countries
  • 32.2. CGM Technology Convenient for both Patients & Physicians

33. Challenges

  • 33.1. Controversy regarding Clinical Benefits

List of Figures:

  • Figure 2-1: Europe-CGM User (Number), 2010-2017
  • Figure 2-2: Europe-Forecast for CGM User (Number), 2018-2024
  • Figure 3-1: Europe-CGM Market (Million US$), 2010-2017
  • Figure 3-2: Europe-Forecast for CGM Market (Million US$), 2018-2024
  • Figure 4-1: Europe-Glucose Sensor Market (Million US$), 2010-2017
  • Figure 4-2: Europe-Forecast for Glucose Sensor Market (Million US$), 2018-2024
  • Figure 4-3: Europe-CGM Transmitter Market (Million US$), 2010-2017
  • Figure 4-4: Europe-Forecast for CGM Transmitter Market (Million US$), 2018-2024
  • Figure 5-1: Europe-CGM Market Share by Countries (Percent), 2010-2017
  • Figure 5-2: Europe-Forecast for CGM Market Share by Countries (Percent), 2018-2024
  • Figure 7-1: Abbott Freestyle Libre-User in Europe & Global (Number), May 2017
  • Figure 8-1: United Kingdom: Diabetes Population (Thousand), 2010-2017
  • Figure 8-2: United Kingdom: Forecast for Diabetes Population (Thousand), 2018-2024
  • Figure 8-3: United Kingdom: Type 1 Diabetes Population (Thousand), 2010-2017
  • Figure 8-4: United Kingdom: Forecast for Type 1 Diabetes Population (Thousand), 2018-2024
  • Figure 8-5: United Kingdom: Type 2 Diabetes Population (Thousand), 2010-2017
  • Figure 8-6: United Kingdom: Forecast for Type 2 Diabetes Population (Thousand), 2018-2024
  • Figure 9-1: United Kingdom-CGM Market (Million US$), 2010-2017
  • Figure 9-2: United Kingdom-Forecast for CGM Market (Million US$), 2018-2024
  • Figure 9-3: United Kingdom-Glucose Sensor Market (Million US$), 2010-2017
  • Figure 9-4: United Kingdom-Forecast for Glucose Sensor Market (Million US$), 2018-2024
  • Figure 9-5: United Kingdom-CGM Transmitter Market (Million US$), 2010-2017
  • Figure 9-6: United Kingdom-Forecast for CGM Transmitter Market (Million US$), 2018-2024
  • Figure 10-1: United Kingdom-CGM User (Number), 2010-2017
  • Figure 10-2: United Kingdom-Forecast for CGM User (Number), 2018-2024
  • Figure 12-1: Germany: Diabetes Population (Thousand), 2010-2017
  • Figure 12-2: Germany: Forecast for Diabetes Population (Thousand), 2018-2024
  • Figure 12-3: Germany: Type 1 Diabetes Population (Thousand), 2010-2017
  • Figure 12-4: Germany: Forecast for Type 1 Diabetes Population (Thousand), 2018-2024
  • Figure 12-5: Germany: Type 2 Diabetes Population (Thousand), 2010-2017
  • Figure 12-6: Germany: Forecast for Type 2 Diabetes Population (Thousand), 2018-2024
  • Figure 13-1: Germany-CGM Market (Million US$), 2010-2017
  • Figure 13-2: Germany-Forecast for CGM Market (Million US$), 2018-2024
  • Figure 13-3: Germany-Glucose Sensor Market (Million US$), 2010-2017
  • Figure 13-4: Germany-Forecast for Glucose Sensor Market (Million US$), 2018-2024
  • Figure 13-5: Germany-CGM Transmitter Market (Million US$), 2010-2017
  • Figure 13-6: Germany-Forecast for CGM Transmitter Market (Million US$), 2018-2024
  • Figure 14-1: Germany-CGM User (Number), 2010-2017
  • Figure 14-2: Germany-Forecast for CGM User (Number), 2018-2024
  • Figure 16-1: Netherlands: Diabetes Population (Thousand), 2010-2017
  • Figure 16-2: Netherlands: Forecast for Diabetes Population (Thousand), 2018-2024
  • Figure 16-3: Netherlands: Type 1 Diabetes Population (Thousand), 2010-2017
  • Figure 16-4: Netherlands: Forecast for Type 1 Diabetes Population (Thousand), 2018-2024
  • Figure 16-5: Netherlands: Type 2 Diabetes Population (Thousand), 2010-2017
  • Figure 16-6: Netherlands: Forecast for Type 2 Diabetes Population (Thousand), 2018-2024
  • Figure 17-1: Netherlands-CGM Market (Million US$), 2010-2017
  • Figure 17-2: Netherlands-Forecast for CGM Market (Million US$), 2018-2024
  • Figure 17-3: Netherlands-Glucose Sensor Market (Million US$), 2010-2017
  • Figure 17-4: Netherlands-Forecast for Glucose Sensor Market (Million US$), 2018-2024
  • Figure 17-5: Netherlands-CGM Transmitter Market (Million US$), 2010-2017
  • Figure 17-6: Netherlands-Forecast for CGM Transmitter Market (Million US$), 2018-2024
  • Figure 18-1: Netherlands-CGM User (Number), 2010-2017
  • Figure 18-2: Netherlands-Forecast for CGM User (Number), 2018-2024
  • Figure 20-1: Sweden: Diabetes Population (Thousand), 2010-2017
  • Figure 20-2: Sweden: Forecast for Diabetes Population (Thousand), 2018-2024
  • Figure 20-3: Sweden: Type 1 Diabetes Population (Thousand), 2010-2017
  • Figure 20-4: Sweden: Forecast for Type 1 Diabetes Population (Thousand), 2018-2024
  • Figure 20-5: Sweden: Type 2 Diabetes Population (Thousand), 2010-2017
  • Figure 20-6: Sweden: Forecast for Type 2 Diabetes Population (Thousand), 2018-2024
  • Figure 21-1: Sweden-CGM Market (Million US$), 2010-2017
  • Figure 21-2: Sweden-Forecast for CGM Market (Million US$), 2018-2024
  • Figure 21-3: Sweden-Glucose Sensor Market (Million US$), 2010 -2017
  • Figure 21-4: Sweden-Forecast for Glucose Sensor Market (Million US$), 2018 -2024
  • Figure 21-5: Sweden-CGM Transmitter Market (Million US$), 2010-2017
  • Figure 21-6: Sweden-Forecast for CGM Transmitter Market (Million US$), 2018-2024
  • Figure 22-1: Sweden-CGM User (Number), 2010-2017
  • Figure 22-2: Sweden-Forecast for CGM User (Number), 2018-2024
  • Figure 24-1: France-Diabetes Population (Thousand), 2010-2017
  • Figure 24-2: France-Forecast for Diabetes Population (Thousand), 2018-2024
  • Figure 24-3: France-Type 1 Diabetes Population (Thousand), 2010-2017
  • Figure 24-4: France-Forecast for Type 1 Diabetes Population (Thousand), 2018-2024
  • Figure 24-5: France-Type 2 Diabetes Population (Thousand), 2010-2017
  • Figure 24-6: France-Forecast for Type 2 Diabetes Population (Thousand), 2018-2024
  • Figure 25-1: France-CGM Market (Million US$), 2010-2017
  • Figure 25-2: France-Forecast for CGM Market (Million US$), 2018-2024
  • Figure 25-3: France-Glucose Sensor Market (Million), 2010-2017
  • Figure 25-4: France-Forecast for Glucose Sensor Market (Million), 2018-2024
  • Figure 25-5: France-CGM Transmitter Market (Million US$), 2010-2017
  • Figure 25-6: France-Forecast for CGM Transmitter Market (Million US$), 2018-2024
  • Figure 26-1: France-CGM User (Number), 2010 -2017
  • Figure 26-2: France-Forecast for CGM User (Number), 2018 -2024
  • Figure 28-1: Switzerland: Diabetes Population (Thousand), 2010-2017
  • Figure 28-2: Switzerland: Forecast for Diabetes Population (Thousand), 2018-2024
  • Figure 28-3: Switzerland: Type 1 Diabetes Population (Thousand), 2010-2017
  • Figure 28-4: Switzerland: Forecast for Type 1 Diabetes Population (Thousand), 2018-2024
  • Figure 28-5: Switzerland: Type 2 Diabetes Population (Thousand), 2010-2017
  • Figure 28-6: Switzerland: Forecast for Type 2 Diabetes Population (Thousand), 2018-2024
  • Figure 29-1: Switzerland-CGM Market (Million US$), 2010-2017
  • Figure 29-2: Switzerland-Forecast for CGM Market (Million US$), 2018-2024
  • Figure 29-3: Switzerland-Glucose Sensor Market (Million US$), 2010-2017
  • Figure 29-4: Switzerland-Forecast for Glucose Sensor Market (Million US$), 2018-2024
  • Figure 29-5: Switzerland-CGM Transmitter Market (Million US$), 2010-2017
  • Figure 29-6: Switzerland-Forecast for CGM Transmitter Market (Million US$), 2018-2024
  • Figure 30-1: Switzerland-CGM User (Number), 2010-2017
  • Figure 30-2: Switzerland-Forecast for CGM User (Number), 2018-2024